Rights and permissions
About this article
Cite this article
Ocular adverse effects with tolterodine and oxybutynin. Inpharma Wkly. 1496, 16 (2005). https://doi.org/10.2165/00128413-200514960-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514960-00048